Literature DB >> 15341680

Regional therapy of liver metastases.

Jonathan Whisenant1, Alan Venook.   

Abstract

Liver metastases usually represent disseminated cancer; therefore, systemic chemotherapy is always appropriate. However, in some instances, the liver is the only site of metastasis and regional control of liver tumors may have important palliative and survival benefits, including a possibility of cure in selected patients. This review identifies unique patient subgroups that may benefit from regional therapy of liver metastases, and considers different treatment options and when these different options may be indicated.

Entities:  

Mesh：

Year:  2004        PMID： 15341680     DOI： 10.1007/s11864-004-0032-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN： 1534-6277


  46 in total

1.  Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.

Authors:  M Lorenz; H H Müller
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)

Authors:  M Lorenz; H H Müller; H Schramm; H J Gassel; H G Rau; K Ridwelski; J Hauss; R Stieger; K W Jauch; W O Bechstein; A Encke
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

3.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

4.  Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.

Authors:  C G Leichman; J R Jacobson; M Modiano; J R Daniels; M M Zalupski; J H Doroshow; W S Fletcher; J S Macdonald
Journal:  Cancer       Date:  1999-09-01       Impact factor: 6.860

5.  Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma.

Authors:  Y H Kim; J A Ajani; C H Carrasco; P Dumas; W Richli; D Lawrence; V Chuang; S Wallace
Journal:  Cancer Invest       Date:  1999       Impact factor: 2.176

6.  Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma.

Authors:  N Kemeny; J A Conti; A Cohen; P Campana; Y Huang; W J Shi; J Botet; S Pulliam; J R Bertino
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

7.  Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial.

Authors:  David J Kerr; Colin S McArdle; Jonathan Ledermann; Irving Taylor; David J Sherlock; Peter M Schlag; John Buckels; David Mayer; Dionne Cain; Richard J Stephens
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

8.  Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors.

Authors:  Alain Roche; Baragur V Girish; Thierry de Baère; Eric Baudin; Valérie Boige; Dominique Elias; Philippe Lasser; Martin Schlumberger; Michel Ducreux
Journal:  Eur Radiol       Date:  2002-07-23       Impact factor: 5.315

9.  Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

Authors:  P Ruszniewski; P Rougier; A Roche; P Legmann; A Sibert; S Hochlaf; M Ychou; M Mignon
Journal:  Cancer       Date:  1993-04-15       Impact factor: 6.860

10.  Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases.

Authors:  Stefan Heinrich; Henrik Petrowsky; Ingo Schwinnen; Elsbeth Staib-Sebler; Christiane Gog; Ahmed El-Ganainy; Carsten Gutt; Hans-Helge Müller; Matthias Lorenz
Journal:  Surgery       Date:  2003-01       Impact factor: 3.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.